A C-reactive protein detection kit

By using stabilizers such as sodium chloride and goat serum in the C-reactive protein detection kit, the problem of insufficient stability of the kit is solved, the appearance of 0 values ​​is avoided, the accuracy and stability of the detection is improved, and it is suitable for marketing promotion. .

CN115015559BActive Publication Date: 2024-12-06BIOBASE BIODUSTRY (SHANDONG) CO LTD
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202210687649.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-06-17
Publication Date
2024-12-06
Estimated Expiration
2042-06-17

AI Technical Summary

Technical Problem

The stability of the C-reactive protein detection kit is poor, resulting in the serum samples being prone to 0 values ​​during detection, affecting the accuracy of the detection.

Method used

Use sodium chloride plasma stabilizers in the kit and add goat serum as a blocking agent to improve the stability and binding force of the solution and avoid the occurrence of 0 values.

Benefits of technology

It effectively improves the stability and binding force of the kit, avoids the situation of 0 values, maintains the accuracy of detection and analysis sensitivity, and is suitable for marketing promotion.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0003700272390000051
    Figure BDA0003700272390000051
  • Figure BDA0003700272390000052
    Figure BDA0003700272390000052
  • Figure BDA0003700272390000061
    Figure BDA0003700272390000061
Patent Text Reader

Abstract

The present invention belongs to the technical field of clinical in vitro detection reagents, and discloses a C-reactive protein detection kit, wherein the stabilizer in the R1 reagent and the stabilizer in the R2 reagent are both salts, and the salt is selected from one or more of sodium chloride, disodium edetate, sodium dextran sulfate, sodium hexametaphosphate, sodium glutamate, sodium hydrogen tartrate, magnesium chloride or potassium chloride; the R2 reagent also includes a CRP antibody and a blocking agent, and the blocking agent is bovine serum albumin containing goat serum. Adding goat serum as a protective agent to the blocking agent can make the stability of BSA better, thereby improving the stability of the reagent. In addition, adding a stabilizer such as sodium chloride ion to the reagent can increase the density and viscosity of the solution, so that the solution plays a good stabilizing role, has a strong binding force with the C-reactive protein in the sample to be tested, and makes the reaction more sensitive.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of clinical in vitro detection reagents, and particularly relates to a C-reactive protein detection kit (immunoturbidimetry). Background Art

[0002] The statements herein merely provide background information related to the present invention and do not necessarily constitute prior art.

[0003] C-reactive protein (CRP) is a protein (acute protein) that rises sharply in the plasma when the body is infected or the tissue is damaged. It activates complement and strengthens the phagocytosis of phagocytes to play a regulatory role, clearing the invading pathogenic microorganisms and damaged, necrotic, and apoptotic tissue cells.

[0004] In clinical practice, the main method for detecting C-reactive protein is immunoturbidimetry, and some laboratories use chemiluminescence and colloidal gold methods for detection. The C-reactive protein detection kit (immunoturbidimetry) does not require sample pretreatment, can achieve automated detection, and can simultaneously measure a large number of specimens. However, the inventors found in actual work that due to the poor stability of the C-reactive protein detection reagent, serum samples are prone to zero values ​​during detection, affecting the accuracy of the detection. Summary of the invention

[0005] In view of the shortcomings of the prior art, the purpose of the present invention is to provide a C-reactive protein detection kit (immunoturbidimetry). The kit has good stability when detecting C-reactive protein and can effectively solve the problem that serum samples are prone to zero values.

[0006] In order to achieve the above object, the present invention is implemented through the following technical solutions:

[0007] A C-reactive protein detection kit, wherein the stabilizer in the R1 reagent and the stabilizer in the R2 reagent are both salts, and the salt is selected from one or more of sodium chloride, disodium edetate, sodium dextran sulfate, sodium hexametaphosphate, sodium glutamate, sodium hydrogen tartrate, magnesium chloride or potassium chloride;

[0008] The R2 reagent also includes a CRP antibody and a blocking agent, wherein the blocking agent is bovine serum albumin containing goat serum.

[0009] The beneficial effects of the present invention are as follows:

[0010] In the C-reactive protein detection kit provided by the present invention, the blocking agent bovine serum albumin (BSA) in reagent R2 can play a good colloidal protective and stabilizing role on the antibody, but the binding effect between the bovine serum albumin (BSA) and the C-reactive protein antibody and the C-reactive protein in the sample is poor, and the sample test result is easily 0. In addition, the stability is poor and it usually denatures or fails in a heated environment, thereby losing the effect and stabilizing effect of the blocking agent itself.

[0011] Adding goat serum as a protective agent to the blocking agent can make BSA more stable, thereby improving the stability of the reagent. In addition, adding ion stabilizers such as sodium chloride to the reagent can increase the density and viscosity of the solution, making the solution have a good stabilizing effect, and have a strong binding force with the C-reactive protein in the sample to be tested, making the reaction more sensitive, but it will not affect the accuracy, linearity and analytical sensitivity of the reagent, which is conducive to the further promotion of the reagent in the market. DETAILED DESCRIPTION

[0012] It should be noted that the following detailed descriptions are illustrative and intended to provide further explanation of the present invention. Unless otherwise specified, all technical and scientific terms used in the present invention have the same meanings as those commonly understood by those skilled in the art to which the present invention belongs.

[0013] A C-reactive protein detection kit, wherein the stabilizer in the R1 reagent and the stabilizer in the R2 reagent are both salts, and the salt is selected from one or more of sodium chloride, disodium edetate, sodium dextran sulfate, sodium hexametaphosphate, sodium glutamate, sodium hydrogen tartrate, magnesium chloride or potassium chloride;

[0014] The R2 reagent also includes a CRP antibody and a blocking agent, wherein the blocking agent is bovine serum albumin containing goat serum.

[0015] In some embodiments, the mass fraction of salt in reagent R1 and reagent R2 is 0.1-15%. For example, the concentration of the salt solution can be 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%.

[0016] Preferably, the salt contains at least sodium chloride.

[0017] Further preferably, the salt contains sodium chloride and at least one selected from disodium edetate, sodium dextran sulfate, sodium hexametaphosphate, sodium glutamate, sodium hydrogen tartrate, magnesium chloride or potassium chloride.

[0018] Further preferably, in the R1 reagent and the R2 reagent, the concentration of sodium chloride is 5-15 g / L, preferably 7-13 g / L, such as 5 g / L, 6 g / L, 7 g / L, 8 g / L, 9 g / L, 10 g / L, 11 g / L, 12 g / L, 13 g / L, 14 g / L, 15 g / L.

[0019] In some embodiments, the mass percentage of goat serum in the blocking agent is 0.1-5%.

[0020] Preferably, in the reagent R2, the mass fraction of the blocking agent is 0.1-15%.

[0021] Further preferably, the mass percentage of goat serum in reagent R2 is 0.3%-0.75%.

[0022] In some embodiments, the CRP antibody is a goat anti-human CRP antibody.

[0023] In some embodiments, the reagent R1 further includes one, two or three of a buffer, a preservative or a surfactant;

[0024] The buffer is selected from one or more of a MOPS buffer, a potassium dihydrogen phosphate-dipotassium hydrogen phosphate buffer or a tris(hydroxymethylaminomethane)-hydrochloric acid buffer;

[0025] The preservative is selected from one or more of PC-300, sodium azide or gentamicin;

[0026] The surfactant is PEG10000 and / or Tween-20.

[0027] In some embodiments, reagent R1 further includes a buffer and / or a preservative;

[0028] The buffer is selected from one or more of a MOPS buffer, a potassium dihydrogen phosphate-dipotassium hydrogen phosphate buffer or a tris(hydroxymethylaminomethane)-hydrochloric acid buffer;

[0029] The preservative is selected from one or more of PC-300, sodium azide or gentamicin.

[0030] The present invention will be further described below in conjunction with the embodiments.

[0031] Example 1

[0032] A C-reactive protein detection kit includes reagent R1, reagent R2 and a calibrator. Reagent R1 is composed of:

[0033] MOPS buffer (pH 7.2) 50 mmol / L;

[0034] PEG10000 4%;

[0035] NaCl 12.5 g / L;

[0036] Dextran sulfate sodium 1.2 mg / mL;

[0037] Dextran 10 mg / mL;

[0038] Sodium hexametaphosphate 0.5g / L;

[0039] Disodium EDTA 3g / L;

[0040] Sodium azide 0.03%;

[0041] Reagent R2 consists of:

[0042]

[0043] The specific determination method is:

[0044] When in use, the determination method is to use an automatic biochemical analyzer, such as the Hitachi 7180 automatic analyzer, and the operation is as follows: add 13μl of physiological saline, sample or calibrator, then add 180μl of reagent 1 and incubate for 5 minutes, record the absorbance value A1, add 60μl of reagent 2, record the absorbance value A2 after 5 minutes, and calculate ΔA.

[0045] The calibration material used in this embodiment is the calibration material produced by Beijing Jiuqiang Company.

[0046] Example 2

[0047] A C-reactive protein detection kit includes reagent R1, reagent R2 and a calibrator. Reagent R1 is composed of:

[0048]

[0049]

[0050] Reagent R2 consists of:

[0051]

[0052] The specific determination method is the same as in Example 1.

[0053] Example 3

[0054] A C-reactive protein detection kit includes reagent R1, reagent R2 and a calibrator. Reagent R1 is composed of:

[0055]

[0056]

[0057] Reagent R2 consists of:

[0058]

[0059] The specific determination method is the same as in Example 1.

[0060] Comparative Example 1

[0061] A C-reactive protein (CRP) assay kit (immunoturbidimetric method) that is recognized on the market.

[0062] Reagent R1 is composed of:

[0063]

[0064] The specific determination method is as in Example 1.

[0065] The analytical performance of the kits prepared in the above comparative examples and embodiments was experimentally verified.

[0066] Accuracy verification experiment:

[0067] The kit of the embodiment was used as the experimental group, and the C-reactive protein detection kit recognized on the market in Comparative Example 1 was used as the control group for comparative experiments. The CRP quality control substances with two different concentrations, high and low, were tested three times respectively. The test results are shown in Table 1:

[0068] Table 1 Accuracy verification test results

[0069]

[0070] It can be seen from the test data in Table 1 that the relative deviations of the test results of the four groups of example test kits and the control kit from the target values ​​of the quality control material are all within 15%, which meets the technical requirements of the enterprise, indicating that the kit of the present invention is highly consistent with the C-reactive protein detection kit recognized on the market, proving that the various other ingredients added to the kit of the present invention will not affect its accuracy, and the kit still maintains good accuracy.

[0071] Analytical sensitivity verification experiment:

[0072] The sample with a known concentration of 0.4 mg / dL was tested with a C-reactive protein detection kit, and the absorbance change rate (ΔA / min) was recorded. The reagents of comparative example 1 and the three groups of embodiments were used for detection. The test results are shown in Table 2:

[0073] Table 2 Analytical sensitivity verification test results

[0074]

[0075] It can be seen from the test data that the various other components added to the kit of the present invention will not affect its analytical sensitivity, and the kit still maintains a good analytical sensitivity.

[0076] Comparative test verification

[0077] A comparative experiment was conducted using the kit of the embodiment as the experimental group and the C-reactive protein detection kit recognized on the market in comparative example 1 as the control group. 40 samples were tested, and the test results are shown in Table 3.

[0078] Table 3 Sample verification test results

[0079]

[0080]

[0081] It can be seen from the test data that the test kits of Example 1, Example 2, and Example 3 of the present invention basically do not have a value of 0, indicating that adding stabilizers such as sodium chloride, NaCl, sodium dextran sulfate, dextran, sodium hexametaphosphate, disodium EDTA, PEG10000, etc. to the reagents can avoid the appearance of a value of 0, among which the content of sodium chloride accounts for the majority, indicating that sodium chloride is the main role, and other properties of the test kit can be maintained at a high level.

[0082] Stability verification experiment:

[0083] The kits of the three examples were placed at 37°C for 7 days, and the results were measured three times at 0, 1, 3, 5 and 7 days, and the average value was taken to compare with the test results of the fresh reagent of Comparative Example 1. The test data are shown in Table 4.

[0084] Table 4 Stability verification test results

[0085]

[0086]

[0087] The experimental results show that the reagent of Comparative Example 1 was stored at 37°C in a light-proof environment without corrosive gases for 7 days, and the test result was reduced by 3.01%, while the reagents of Examples 1, 2, and 3 were stored at 37°C in a light-proof environment without corrosive gases for 7 days and the test results were reduced by 1.08%, 1.51%, and 1.08%, respectively, and the reduction was less than that of Comparative Example 1, among which the reduction in Examples 1 and 3 was smaller than that in Example 2, indicating that the addition of goat serum to the reagent effectively increased the stability of the reagent.

[0088] Based on the above analysis, the C-reactive protein detection kit provided by the present invention can effectively avoid the appearance of 0 value by adding stabilizers such as sodium chloride, NaCl, sodium dextran sulfate, dextran, sodium hexametaphosphate, disodium EDTA, PEG10000, etc. to the reagent, and adding goat serum to the reagent can effectively increase the stability of the reagent without affecting the change of other properties. Therefore, the C-reactive protein detection kit provided by the present invention is conducive to further promotion and use in the market.

[0089] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A C-reactive protein detection kit, characterized in that: The stabilizer in the R1 reagent and the stabilizer in the R2 reagent are both salts, and the salt is selected from one or more of sodium chloride, disodium edetate, sodium dextran sulfate, sodium hexametaphosphate, sodium glutamate, sodium hydrogen tartrate, magnesium chloride or potassium chloride; The R2 reagent also includes a CRP antibody and a blocking agent, wherein the blocking agent is bovine serum albumin containing goat serum; In the blocking agent, the mass percentage of goat serum is 0.1-5%; Reagent R1 also includes one, two or three of a buffer, a preservative or a surfactant; The buffer is selected from one or more of a MOPS buffer, a potassium dihydrogen phosphate-dipotassium hydrogen phosphate buffer or a tris(hydroxymethylaminomethane)-hydrochloric acid buffer; The preservative is selected from one or more of PC-300, sodium azide or gentamicin; The surfactant is PEG10000 and / or Tween-20.

2. The C-reactive protein detection kit according to claim 1, characterized in that: In reagent R1 and reagent R2, the mass fraction of salt is 0.1-15%.

3. The C-reactive protein detection kit according to claim 2, characterized in that: The salt contains at least sodium chloride.

4. The C-reactive protein detection kit according to claim 3, characterized in that: The salt contains sodium chloride and at least one selected from disodium edetate, sodium dextran sulfate, sodium hexametaphosphate, sodium glutamate, sodium hydrogen tartrate, magnesium chloride or potassium chloride; Or, in the R1 reagent and the R2 reagent, the concentration of sodium chloride is 5-15 g / L.

5. The C-reactive protein detection kit according to claim 1, characterized in that: In the reagent R2, the mass fraction of the blocking agent is 0.1-15%.

6. The C-reactive protein detection kit according to claim 5, characterized in that: The mass percentage of goat serum in reagent R2 is 0.3%-0.75%.

7. The C-reactive protein detection kit according to claim 1, characterized in that: The CRP antibody is a goat anti-human CRP antibody.

Citation Information

Patent Citations

  • C reactive protein detection kit

    CN103941017A

  • C-reactive protein detection kit

    CN112034178A

  • Carrier particle latex for assay reagent and assay reagent

    EP1416277A1